Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Fish and Richardson
Merck
Cantor Fitzgerald
Cerilliant
Baxter
Daiichi Sankyo
McKinsey

Generated: October 17, 2018

DrugPatentWatch Database Preview

Braintree Company Profile

« Back to Dashboard

What is the competitive landscape for BRAINTREE, and when can generic versions of BRAINTREE drugs launch?

BRAINTREE has six approved drugs.

There are three US patents protecting BRAINTREE drugs.

Summary for Braintree
US Patents:3
Tradenames:7
Ingredients:6
NDAs:6
Patent Litigation for Braintree: See patent lawsuits for Braintree

Drugs and US Patents for Braintree

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree GOLYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 019011-001 Jul 13, 1984 AA RX Yes Yes ➤ Sign Up ➤ Sign Up
Braintree GOLYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 019011-002 Jun 2, 1992 RX Yes Yes ➤ Sign Up ➤ Sign Up
Braintree Labs SUCLEAR magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate SOLUTION;ORAL 203595-001 Jan 18, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for BRAINTREE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Oral Solution and Delayed- 210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg ➤ Subscribe 2008-01-28
➤ Subscribe Oral Solution 15 mg/mL ➤ Subscribe 2008-05-14
➤ Subscribe For Oral Solution and Delayed-release Tablet 210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg (1 Tablet Regimen) ➤ Subscribe 2010-07-30
➤ Subscribe Oral Solution 17.5 g/3.13 g/1.6 g per bottle ➤ Subscribe 2010-11-08

Supplementary Protection Certificates for Braintree Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012000051 Germany ➤ Sign Up PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
00615 Netherlands ➤ Sign Up PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
C/GB01/006 United Kingdom ➤ Sign Up PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Medtronic
Chinese Patent Office
Colorcon
Boehringer Ingelheim
US Department of Justice
US Army
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.